相关实验视频

Updated: Jul 4, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

解开医学奥秘:通过药物重新定位来预防缺陷性中风

Linjing Zhang¹, Fan Wang¹, Kailin Xia¹

¹Department of Neurology, Peking University Third Hospital, Beijing 100191, China.

|January 26, 2024

概括

某些药物,包括通道阻断剂和他类药物,在预防内中风方面表现有前途. 这项研究确定了可以降低中风风险和促进大脑健康的特定药物标.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.
遗传学遗传学是一个

背景情况:

缺陷性中风预防目前依赖于一般风险因素管理.
具体的药物因果关系,以减少沟性中风风险仍然不清楚.

研究的目的:

通过药物点孟德尔随机化,研究常见的抗高血压,低脂和低血糖药物对缺口中风风险的因果作用.
确定特定的药物类别和点,可以有效地预防缺口性中风.

主要方法:

使用药物标门德尔随机化分析.
跨民族分析利用来自大型元分析的缺口性中风数据 (7338例,254,798对照).
对模仿特定药物作用的基因变异进行了分析,以确定它们与内中风的关联.

主要成果:

模仿通道阻断剂的基因变异证明了对缺口中风的最稳定的保护作用.
预计接近HMGCR,NPC1L1和APOC3的变种,分别模仿他类药物,ezetimibe和anti-apoC3药物,可以减少缺口性中风的发生率.
改善的血糖控制,包括GLP1R激动性,与减少内中风风险有关.

结论:

特定的药物类别,如通道阻塞剂和他类药物,可以比一般的风险因素控制更有效地降低中风风险.
在临床实践中,重新利用现有,安全和成本有效的药物来预防缺口性中风应该是优先考虑的.
这种方法可能会显著促进大脑更健康的衰老.

关键词:

老化的老化衰老的老化这是一种抗高血压剂.药物重用是为了改变药物的用途.遗传关联研究遗传关联研究健康的健康的健康的健康的健康.低血糖药物低血糖药物低血糖药物低脂性血脂抑制剂的使用方法拉库纳尔 (Lacunar) 是一个很小的城市.门德尔的随机化分析分析.精准医学是一门精准医学.预防医学是预防医学.一次性中风中风中风中风中风

更多相关视频

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice

Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice

Published on: October 20, 2016

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...